Module 10 Pharmacovigilance Background definitions Timeline of pharmacovigilance for a drug from development premarket to postmarketing use Burden of adverse drug reactions in children Number of pharmacoepidemiological safety studies in children Osokogu et al 2016 ID: 731494
Download Presentation The PPT/PDF document "Toolkit for research and development of ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Toolkit for research and development of paediatric antiretroviral drugs and formulationsSlide2
Module 10:PharmacovigilanceSlide3
Background – definitionsSlide4
Timeline of pharmacovigilance for a drug from development (pre-market) to post-marketing useSlide5
Burden of adverse drug reactions in childrenSlide6
Number of pharmacoepidemiological safety studies in children (Osokogu et al, 2016)Slide7
Importance of pharmacovigilance in context of expanded antiretroviral therapySlide8
Challenges of antiretroviral therapy pharmacovigilance in low- and middle-income countries (1/2)Slide9
Challenges of antiretroviral therapy pharmacovigilance in low- and middle-income countries (2/2)Slide10
Solutions (1/3)Slide11
Solutions (2/3)Slide12
Solutions (3/3)Slide13
Case studiesSlide14
SummarySlide15
Key considerationsSlide16
Acknowledgements